Drugs Made In Amer Acq Ii (DMII) Stock Price, News & Analysis
Company Description
Drugs Made In Amer Acq Ii (NASDAQ: DMII) is classified in the shell companies industry within the Blank Checks sector and carries a market capitalization of $644.0M, ranking #3,381 among all listed U.S. companies by market cap.
For FY2025, Drugs Made In Amer Acq Ii reported net income of $4.2M.
This page collects what Stock Titan holds for DMII, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Drugs Made In Amer Acq Ii (DMII) stock last closed at $10.11. At a market capitalization of $644.0M, DMII is classified as a small-cap stock with approximately 63.7M shares outstanding.
DMII Rankings
Latest News
SEC Filings
Drugs Made In Amer Acq Ii has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-Q, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on May 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMII SEC filings →
Financial Highlights
operating income reached -$488K, and net income was $4.2M. The company generated -$1.0M in operating cash flow. With a current ratio of 0.09, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Drugs Made In Amer Acq Ii (DMII) currently stands at 46.5 thousand shares, down 20.9% from the previous reporting period, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Drugs Made In Amer Acq Ii (DMII) currently stands at 1.6 days, up 57% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 57% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.8 days.
DMII Company Profile & Sector Positioning
Drugs Made In Amer Acq Ii (DMII) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ. In monthly performance, the stock ranks #2,402 among all tracked companies.